# Joseph L. Lillo, D.O. – FDA Inspection, Mar 22, 2021

Source: https://www.keypedia.com/records/fda_inspections/joseph-l-lillo-do/5a802237-2c7a-4b96-a384-8d98800b915f
Source feed: FDA_Inspections

> FDA inspection 1136939 of Joseph L. Lillo, D.O., March 22, 2021. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1136939
- Company Name: Joseph L. Lillo, D.O.
- Inspection Date: 2021-03-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1112185 - 2019-12-09
- [FDA Inspection 1009887 - 2017-04-17](https://www.keypedia.com/records/fda_inspections/joseph-l-lillo-do/1df67e89-7f5b-42de-9273-2767b9fe60d6)
- [FDA Inspection 1009886 - 2017-04-12](https://www.keypedia.com/records/fda_inspections/joseph-l-lillo-do/46c8c5aa-ab63-47bd-8955-02f814c16650)
- FDA Inspection 866757 - 2014-02-26

Company: https://www.keypedia.com/companies/joseph-l-lillo-do/1ea0d267-f3a4-4b8f-9611-61ba95abc6b1

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
